Skip to main content

Blog

By submitting this form, you agree to receive email communications from Inpart as well as the storing and processing of your personal data by Inpart as detailed in the Privacy Statement. You may unsubscribe from these communications at any time.

Latest articles

All
Connecting
Networking
Execution
Inpart Connect Campaigns hub
Connecting
Inpart Connect Campaigns hub
Promoting Facilities on Inpart: A Guide for TTOs
Promoting Facilities on Inpart: A Guide for TTOs
Top 25 innovations for 2025, identified by the global R&D community
Connecting
Top 25 innovations for 2025, identified by the global R&D community
A life science CRM for the times: Why are top biopharma seeking an end-to-end partnering platform?
Execution
A life science CRM for the times: Why are top biopharma seeking an end-to-end partnering platform?
Top 10 nanotechnology innovations for 2025
Connecting
Top 10 nanotechnology innovations for 2025
17 top healthcare innovations 2024, identified by the global R&D community
Connecting
17 top healthcare innovations 2024, identified by the global R&D community
Why your technology title matters: data-backed tips for success
Why your technology title matters: data-backed tips for success
What are the future trends in sustainable agriculture and food production R&D?
Connecting
What are the future trends in sustainable agriculture and food production R&D?
KoreaBIO partners with industry-leading biopharma partnering platform, Inpart
Execution
KoreaBIO partners with industry-leading biopharma partnering platform, Inpart
13 top agritech innovations for 2024, identified by the global R&D community
Connecting
13 top agritech innovations for 2024, identified by the global R&D community
Inpart and Evaluate announce strategic partnership to optimize biopharma dealmaking
Execution
Inpart and Evaluate announce strategic partnership to optimize biopharma dealmaking
Finding the perfect partner: Biopharma partnering trends from Partnering 2030
Connecting
Finding the perfect partner: Biopharma partnering trends from Partnering 2030
Sustainability in biopharma: how are climate goals being reached through partnering?
Connecting
Sustainability in biopharma: how are climate goals being reached through partnering?
24 top innovations for 2024, identified by the global R&D community
Connecting
24 top innovations for 2024, identified by the global R&D community
Top scouting solutions for R&D in 2024: Traditional vs Digital methods
Connecting
Top scouting solutions for R&D in 2024: Traditional vs Digital methods
10 top biotechnology innovations for industry R&D 2023
Connecting
10 top biotechnology innovations for industry R&D 2023
The need to know for successful alliance management in the life sciences
Execution
The need to know for successful alliance management in the life sciences
23 top innovations for 2023, identified by the global R&D community
Connecting
23 top innovations for 2023, identified by the global R&D community
How to get research patented: a quick guide for academic researchers
Execution
How to get research patented: a quick guide for academic researchers
6 ways to build and extend your network as a scientific researcher
Networking
6 ways to build and extend your network as a scientific researcher
University-industry matchmaking: how companies and academic institutes find new partners
Connecting
University-industry matchmaking: how companies and academic institutes find new partners
Tech transfer market pull: the value of industry feedback and engagement metrics
Connecting
Tech transfer market pull: the value of industry feedback and engagement metrics
University-industry collaboration: A glossary of terms
Execution
University-industry collaboration: A glossary of terms
Why and how to find industry funding for academic research
Connecting
Why and how to find industry funding for academic research
Why should early career researchers be thinking about commercialisation?
Connecting
Why should early career researchers be thinking about commercialisation?
Making a billion dollar pharma deal happen
Connecting
Making a billion dollar pharma deal happen
Alliance management best practices: reducing risk & driving successful partnerships
Execution
Alliance management best practices: reducing risk & driving successful partnerships
Turning introductions into successful university-industry partnerships
Connecting
Turning introductions into successful university-industry partnerships
Counting the real cost of your software choices
Execution
Counting the real cost of your software choices
Communicating science to industry: How to write an effective technology disclosure
Networking
Communicating science to industry: How to write an effective technology disclosure
Why you should invest in compliance
Execution
Why you should invest in compliance
How do R&D teams evaluate new opportunities?
Execution
How do R&D teams evaluate new opportunities?
Collaboration in pharma – today’s business imperative
Connecting
Collaboration in pharma – today’s business imperative
A guide to IP creation, exchange and ownership in university-industry collaborations
Execution
A guide to IP creation, exchange and ownership in university-industry collaborations

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use